Kam MK - Search Results

1

Relationship between pretreatment level of plasma Epstein-Barr virus DNA, tumor burden, and metabolic activity in advanced nasopharyngeal carcinoma.

Ma BB, King A, Lo YM, Yau YY, Zee B, Hui EP, Leung SF, Mo F, Kam MK, Ahuja A, Kwan WH, Chan AT. Ma BB, et al. Among authors: kam mk. Int J Radiat Oncol Biol Phys. 2006 Nov 1;66(3):714-20. doi: 10.1016/j.ijrobp.2006.05.064. Int J Radiat Oncol Biol Phys. 2006. PMID: 17011447

2

Dosimetric comparison of intensity-modulated stereotactic radiotherapy with other stereotactic techniques for locally recurrent nasopharyngeal carcinoma.

Kung SW, Wu VW, Kam MK, Leung SF, Yu BK, Ngai DY, Wong SC, Chan AT. Kung SW, et al. Among authors: kam mk. Int J Radiat Oncol Biol Phys. 2011 Jan 1;79(1):71-9. doi: 10.1016/j.ijrobp.2009.10.044. Epub 2010 Apr 10. Int J Radiat Oncol Biol Phys. 2011. PMID: 20385452

3

Prognostic significance of the total dose of cisplatin administered during concurrent chemoradiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma.

Loong HH, Ma BB, Leung SF, Mo F, Hui EP, Kam MK, Chan SL, Yu BK, Chan AT. Loong HH, et al. Among authors: kam mk. Radiother Oncol. 2012 Sep;104(3):300-4. doi: 10.1016/j.radonc.2011.12.022. Epub 2012 Jan 31. Radiother Oncol. 2012. PMID: 22300609

4

Phase II study of neoadjuvant carboplatin and paclitaxel followed by radiotherapy and concurrent cisplatin in patients with locoregionally advanced nasopharyngeal carcinoma: therapeutic monitoring with plasma Epstein-Barr virus DNA.

Chan AT, Ma BB, Lo YM, Leung SF, Kwan WH, Hui EP, Mok TS, Kam M, Chan LS, Chiu SK, Yu KH, Cheung KY, Lai K, Lai M, Mo F, Yeo W, King A, Johnson PJ, Teo PM, Zee B. Chan AT, et al. J Clin Oncol. 2004 Aug 1;22(15):3053-60. doi: 10.1200/JCO.2004.05.178. J Clin Oncol. 2004. PMID: 15284255 Clinical Trial.

5

A phase II study of patients with metastatic or locoregionally recurrent nasopharyngeal carcinoma and evaluation of plasma Epstein-Barr virus DNA as a biomarker of efficacy.

Ma B, Hui EP, King A, To KF, Mo F, Leung SF, Kam M, Lo YM, Zee B, Mok T, Ahuja A, Chan AT. Ma B, et al. Cancer Chemother Pharmacol. 2008 Jun;62(1):59-64. doi: 10.1007/s00280-007-0575-8. Epub 2007 Aug 29. Cancer Chemother Pharmacol. 2008. PMID: 17762933 Clinical Trial.

6

Radiation injury of the parotid glands during treatment for head and neck cancer: assessment using dynamic contrast-enhanced MR imaging.

Lee FK, King AD, Kam MK, Ma BB, Yeung DK. Lee FK, et al. Among authors: kam mk. Radiat Res. 2011 Mar;175(3):291-6. doi: 10.1667/RR2370.1. Epub 2011 Jan 10. Radiat Res. 2011. PMID: 21388272

7

Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma--correlation with excision repair cross-complementing-1 polymorphisms.

Ma BB, Hui EP, Wong SC, Tung SY, Yuen KK, King A, Chan SL, Leung SF, Kam MK, Yu BK, Zee B, Chan AT. Ma BB, et al. Among authors: kam mk. Ann Oncol. 2009 Nov;20(11):1854-9. doi: 10.1093/annonc/mdp065. Epub 2009 Jun 23. Ann Oncol. 2009. PMID: 19549713 Free article. Clinical Trial.

8

Randomized phase II trial of concurrent cisplatin-radiotherapy with or without neoadjuvant docetaxel and cisplatin in advanced nasopharyngeal carcinoma.

Hui EP, Ma BB, Leung SF, King AD, Mo F, Kam MK, Yu BK, Chiu SK, Kwan WH, Ho R, Chan I, Ahuja AT, Zee BC, Chan AT. Hui EP, et al. Among authors: kam mk. J Clin Oncol. 2009 Jan 10;27(2):242-9. doi: 10.1200/JCO.2008.18.1545. Epub 2008 Dec 8. J Clin Oncol. 2009. PMID: 19064973 Clinical Trial.

9

Meta-analysis of chemotherapy in nasopharynx carcinoma (MAC-NPC): An update on 26 trials and 7080 patients.

Blanchard P, Lee AWM, Carmel A, Wai Tong N, Ma J, Chan ATC, Hong RL, Chen MY, Chen L, Li WF, Huang PY, Kwong DLW, Poh SSX, Ngan R, Mai HQ, Ollivier C, Fountzilas G, Zhang L, Bourhis J, Aupérin A, Lacas B, Pignon JP; MAC-NPC collaborative Group. Blanchard P, et al. Clin Transl Radiat Oncol. 2021 Nov 26;32:59-68. doi: 10.1016/j.ctro.2021.11.007. eCollection 2022 Jan. Clin Transl Radiat Oncol. 2021. PMID: 34935776 Free PMC article.

10

A new prognostic histopathologic classification of nasopharyngeal carcinoma.

Wang HY, Chang YL, To KF, Hwang JS, Mai HQ, Feng YF, Chang ET, Wang CP, Kam MK, Cheah SL, Lee M, Gao L, Zhang HZ, He JH, Jiang H, Ma PQ, Zhu XD, Zeng L, Chen CY, Chen G, Huang MY, Fu S, Shao Q, Han AJ, Li HG, Shao CK, Huang PY, Qian CN, Lu TX, Li JT, Ye W, Ernberg I, Ng HK, Wee JT, Zeng YX, Adami HO, Chan AT, Shao JY. Wang HY, et al. Among authors: kam mk. Chin J Cancer. 2016 May 5;35:41. doi: 10.1186/s40880-016-0103-5. Chin J Cancer. 2016. PMID: 27146632 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

76 results

Search Page